ABCL-396: Incidence, Onset, and Management of Edema and Effusion in Patients Treated with Loncastuximab Tesirine for R/R DLBCL in the LOTIS Clinical Trial Program
2021 ◽
Vol 21
◽
pp. S397-S398
Keyword(s):
2018 ◽
Vol 124
(1)
◽
pp. 27-38
◽
Keyword(s):
Keyword(s):
Keyword(s):